Cargando…

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis

Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) results in accelerated bone loss and increased risk of bone fracture. The aim of the present study was to evaluate serum bone markers—sclerostin, Dickkopf-1 (DKK-1) and osteoprotegerin (OPG), in a cohort of 88 PCa patients without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Alice, Karunasinghe, Nishi, Plank, Lindsay D., Zhu, Shuotun, Osborne, Sue, Brown, Charis, Bishop, Karen, Schwass, Tiffany, Tijono, Sofian, Holmes, Michael, Masters, Jonathan, Huang, Roger, Keven, Christine, Ferguson, Lynnette R., Lawrenson, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295319/ https://www.ncbi.nlm.nih.gov/pubmed/34290287 http://dx.doi.org/10.1038/s41598-021-94090-y

Ejemplares similares

Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study
por: Wang, Alice, et al.
Publicado: (2017)

Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand
por: Wang, Alice, et al.
Publicado: (2015)

Benefits of Selenium Supplementation on Leukocyte DNA Integrity Interact with Dietary Micronutrients: A Short Communication
por: Karunasinghe, Nishi, et al.
Publicado: (2016)

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
por: Karunasinghe, Nishi, et al.
Publicado: (2016)

Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts
por: Karunasinghe, Nishi, et al.
Publicado: (2018)

An Investigation into the Association between DNA Damage and Dietary Fatty Acid in Men with Prostate Cancer
por: Bishop, Karen S., et al.
Publicado: (2015)

Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand
por: Karunasinghe, Nishi, et al.
Publicado: (2019)

Selenium Supplementation and Prostate Health in a New Zealand Cohort
por: Karunasinghe, Nishi, et al.
Publicado: (2019)

Suppression of Sost/Sclerostin and Dickkopf‐1 Augment Intervertebral Disc Structure in Mice
por: Kroon, Tori, et al.
Publicado: (2022)

Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
por: Gerov, Vladimir, et al.
Publicado: (2023)

An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer
por: Bishop, Karen S., et al.
Publicado: (2016)

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

The role of sclerostin and dickkopf-1 in oral tissues – A review from the perspective of the dental disciplines
por: Samiei, Mohammad, et al.
Publicado: (2019)

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020)

Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis
por: Gómez-Vaquero, Carmen, et al.
Publicado: (2016)

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
por: Lawrenson, Ross, et al.
Publicado: (2014)

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions
por: Karunasinghe, Nishi, et al.
Publicado: (2022)

Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction
por: Shui, Xing, et al.
Publicado: (2022)

Nutrigenetics, Nutrigenomics, and Selenium
por: Ferguson, Lynnette R., et al.
Publicado: (2011)

Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
por: Kwilas, Anna R., et al.
Publicado: (2016)

Changes in expression of Wnt signaling pathway inhibitors dickkopf-1 and sclerostin before and after total joint arthroplasty
por: Lu, Ke, et al.
Publicado: (2017)

A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet
por: Erdrich, Sharon, et al.
Publicado: (2015)

Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients
por: Marlow, Gareth, et al.
Publicado: (2013)

Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
por: Choi, Hong Y., et al.
Publicado: (2009)

The Influence of Pro-Inflammatory Factors on Sclerostin and Dickkopf-1 Production in Human Dental Pulp Cells Under Hypoxic Conditions
por: Janjić, Klara, et al.
Publicado: (2019)

Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients
por: Bahie, Ahmed, et al.
Publicado: (2021)

Changes in Dickkopf-1 (DKK1) and Sclerostin following a Loading Dose of Vitamin D(2) (300,000 IU)
por: Sankaralingam, A., et al.
Publicado: (2014)

A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures
por: Ramli, Fitri Fareez, et al.
Publicado: (2020)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment
por: Jang, Eunhee, et al.
Publicado: (2021)

Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APC(MIN) Mouse Model
por: Asadi, Khalid, et al.
Publicado: (2017)

Associations of serum sclerostin and Dickkopf-related protein-1 proteins with future cardiovascular events and mortality in haemodialysis patients: a prospective cohort study
por: Stavrinou, Eirini, et al.
Publicado: (2020)

Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions
por: Wang, Jian-Hang, et al.
Publicado: (2016)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model
por: Shuid, Ahmad Nazrun, et al.
Publicado: (2012)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Do hypoxia and L-mimosine modulate sclerostin and dickkopf-1 production in human dental pulp-derived cells? Insights from monolayer, spheroid and tooth slice cultures
por: Janjić, Klara, et al.
Publicado: (2018)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Zinc in Prostate Health and Disease: A Mini Review
por: Karunasinghe, Nishi
Publicado: (2022)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dk3eiivgv2v1f56oj45mo998fe